(Reuters) – Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker’s shareholders, and ally Pershing Square called for a meeting to turn over the target company’s board.
Pershing Square Chief...
Valeant, Pershing go hostile in $53.8 billion Allergan bid
No comments:
Post a Comment